InspireMD introduces
MGuardTM, a novel stent system that addresses
Acute Coronary Syndromes. MGuard is based on
a unique technology that minimizes distal embolization
in complex thrombotic situations. The MGuard
system is showing very successful results in
clinical trials across Europe.
The Mguard™ Technology
Mguard™ is
based on a stent which is wrapped with an expandable,
micron level knit
net.
During stenting, emboli can be released
into circulation, potentially leading to lower
blush
and life-threatening complications.
In Acute
MI patients, no-reflow and reduced perfusion,
which are direct consequences of
embolic showers, may translate into myocardial
injury and mortality.
As opposed to current
stents Mguard™ diffuses
the stent pressure and reduces injury to the
vessel thereby lowering restenosis and late
loss without exposing the patient to the complications
associated with DES.
The expandable, micron-level
net is made of a single knitted PET fiber.
The net is attached
to the stent at the proximal and distal side
of the stent, and expands seamlessly during
stent deployment. The net may also perform
as an efficient drug delivery platform as it
provides a more uniform and wider coverage
of the arterial wall.
Mguard™ is deployed
exactly like a typical balloon inflated stent.
Deliverability and
crossing profile remain the same and dilatation
pressure is not affected. The net reduces the
risk of plaque rupture and embolisation providing
double protection during and post procedure.
Mguard™ has CE mark and is indicated
for treating patients with coronary artery
disease. Mguard™ is recommended for use
in Acute coronary syndrome, especially in Acute
MI, as the net reduces embolisation, and enables
excellent myocardial blush and flow. Mguard™ is
also suitable for SVG and arteries with thrombus.
Mguard™ Carotid and Peripheral will follow
soon.
